iGEM bioinnovation fair

iGEM bioinnovation fair
date
October 30, 2025
TIme
Address

Paris Convention Centre

The 2025 iGEM Grand Jamboree brought together a global community passionate about synthetic biology. From researchers to entrepreneurs, people came together to share ideas and explore what’s next for biotech.

Potter Clarkson is proud to be part of the conversation, highlighting how thoughtful IP strategies can help innovators protect their work and create lasting impact.

Fireside chat: Intellectual property - ask me anything

Interactive fireside chat led by Robert Cogger-Ward at 10:00 AM. This session is a chance to get straight answers to the questions every SynBio innovator faces: where to file, what to protect, and how to talk about IP with investors or the public. Join an open conversation that makes tricky IP topics easy to understand and gives you practical steps you can put into action straight away.

Owning the code of life - from IP pitfalls to winning strategies

At 2:45 PM, Sara Holland joins Nadine Bongaerts from iGEM Foundation for a session titled “Owning the Code of Life – From IP Pitfalls to Winning Strategies.”

The conversation explores an important question: Who owns the code of life and what does that mean for the future of biotechnology? From patent cliffs that threaten billions in pharmaceutical revenue to AI-generated proteins that blur the boundaries of innovation, the rules of intellectual property are changing rapidly. Sara and Nadine will unpack these challenges and share practical advice on how innovators can protect value, manage uncertainty and build strategies that stand the test of time.

These sessions are part of the BioInnovation Summit, a highlight of the iGEM Grand Jamboree.

Kodak v FujiFilm: the Court of Appeal confirms UPC’s long-arm jurisdiction

Kodak v FujiFilm: the Court of Appeal confirms UPC’s long-arm jurisdiction

Comparing EPC Article 53(a) and US patent law in gene editing ethics

Comparing EPC Article 53(a) and US patent law in gene editing ethics

EPO Board of Appeal refers claim interpretation and added matter questions

EPO Board of Appeal refers claim interpretation and added matter questions

Creating an effective IP strategy for CAR-T

Creating an effective IP strategy for CAR-T

When is a synbio company a gene therapy company?

When is a synbio company a gene therapy company?

IAM Patent 1000: The World's Leading Patent Professionals 2026

IAM Patent 1000: The World's Leading Patent Professionals 2026

PCOS name changes to PMOS: Will PCOS’ name change impact patent applications

PCOS name changes to PMOS: Will PCOS’ name change impact patent applications

Drug repurposing in the age of AI: lessons from COVID-19 and the future of second medical use innovation

Drug repurposing in the age of AI: lessons from COVID-19 and the future of second medical use innovation

See All News